{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:43:21Z","timestamp":1784346201992,"version":"3.55.0"},"reference-count":21,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1136\/archdischild-2016-312185","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:55:38Z","timestamp":1493168138000},"page":"830-835","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":39,"title":["Late outcomes in children with Langerhans cell histiocytosis"],"prefix":"10.1136","volume":"102","author":[{"given":"Tin Wai","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Kwan","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frankie Wai Tsoi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar Medhukar","family":"Kumta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie Chiu Wing","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Ming Kong","family":"Shing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Kong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"key":"key-10.1136\/archdischild-2016-312185-1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/adc.2008.144527","article-title":"Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland","volume":"94","author":"Salotti","year":"2009","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/archdischild-2016-312185-2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pbc.21498","article-title":"Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004","volume":"51","author":"Guyot-Goubin","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.1136\/archdischild-2016-312185-3","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1182\/blood-2012-09-455774","article-title":"Therapy prolongation improves outcome in Multisystem langerhans cell histiocytosis","volume":"121","author":"Gadner","year":"2013","journal-title":"Blood"},{"key":"key-10.1136\/archdischild-2016-312185-4","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1067\/mpd.2001.111331","article-title":"A randomized trial of \u00a0treatment for Multisystem langerhans\u2019\u00a0cell histiocytosis","volume":"138","author":"Gadner","year":"2001","journal-title":"J Pediatr"},{"key":"key-10.1136\/archdischild-2016-312185-5","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1182\/blood-2007-08-106211","article-title":"Improved outcome in Multisystem langerhans cell histiocytosis is associated with therapy intensification","volume":"111","author":"Gadner","year":"2008","journal-title":"Blood"},{"key":"key-10.1136\/archdischild-2016-312185-6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/pbc.20021","article-title":"Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the histiocyte Society-Late effects study group","volume":"42","author":"Haupt","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.1136\/archdischild-2016-312185-7","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.ejca.2006.05.031","article-title":"Long term morbidity and health related quality of life after multi-system langerhans cell histiocytosis","volume":"42","author":"Nanduri","year":"2006","journal-title":"Eur J Cancer"},{"key":"key-10.1136\/archdischild-2016-312185-8","volume-title":"Histiocyte society evaluation and treatment guidelines","author":"Minkov","year":"2009"},{"key":"key-10.1136\/archdischild-2016-312185-9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pbc.24367","article-title":"Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years","volume":"60","author":"Haupt","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.1136\/archdischild-2016-312185-10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/pbc.20425","article-title":"DALHX- and LCH I and II study committee. risk factors for diabetes insipidus in Langerhans cell histiocytosis.","volume":"46","author":"Grois","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.1136\/archdischild-2016-312185-11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/pbc.21322","article-title":"Skeletal Langerhans cell histiocytosis in children: permanent consequences and health-related quality of life in long-term survivors","volume":"50","author":"Lau","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.1136\/archdischild-2016-312185-12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1651-2227.2005.tb02048.x","article-title":"Long-term follow-up of Langerhans cell histiocytosis: 39 years\u2019\u00a0experience at a single centre","volume":"94","author":"Bernstrand","year":"2005","journal-title":"Acta Paediatr"},{"key":"key-10.1136\/archdischild-2016-312185-13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0036933014542387","article-title":"Langerhans cell histiocytosis: 23 years\u2019\u00a0paediatric experience highlights severe long-term sequelae","volume":"59","author":"Martin","year":"2014","journal-title":"Scott Med J"},{"key":"key-10.1136\/archdischild-2016-312185-14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MPH.0000000000000054","article-title":"Clinical features and treatment outcomes of Langerhans cell histiocytosis: a nationwide survey from korea histiocytosis working party","volume":"36","author":"Kim","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"key-10.1136\/archdischild-2016-312185-15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jpeds.2010.03.001","article-title":"Histiocyte society CNS LCH study group. central nervous system disease in Langerhans cell histiocytosis","volume":"156","author":"Grois","year":"2010","journal-title":"J Pediatr"},{"key":"key-10.1136\/archdischild-2016-312185-16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131635","article-title":"Early diagnosis and monitoring of neurodegenerative langerhans cell histiocytosis","volume":"10","author":"Sieni","year":"2015","journal-title":"PLoS One"},{"key":"key-10.1136\/archdischild-2016-312185-17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/pbc.22791","article-title":"Incidence and pattern of radiological central nervous system langerhans cell histiocytosis in children: a population based study","volume":"56","author":"Laurencikas","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.1136\/archdischild-2016-312185-18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpeds.2007.12.042","article-title":"Pattern and course of neurodegeneration in langerhans cell histiocytosis","volume":"153","author":"Wnorowski","year":"2008","journal-title":"J Pediatr"},{"key":"key-10.1136\/archdischild-2016-312185-19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12185-014-1717-5","article-title":"Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease","volume":"101","author":"Imashuku","year":"2015","journal-title":"Int J Hematol"},{"key":"key-10.1136\/archdischild-2016-312185-20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/pbc.20040","article-title":"Retinoic acid therapy in\u00a0\u201cdegenerative-like\u201d\u00a0neuro-langerhans cell histiocytosis: a prospective pilot study","volume":"43","author":"Idbaih","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.1136\/archdischild-2016-312185-21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/pbc.22326","article-title":"Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine\/cytosine arabinoside","volume":"54","author":"Allen","year":"2010","journal-title":"Pediatr Blood Cancer"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2016-312185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T11:05:49Z","timestamp":1601118349000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2016-312185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,8,18]]},"published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1136\/archdischild-2016-312185"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2016-312185","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,25]]}}}